Stock 2289 CHARMACY PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Charmacy Pharmaceutical Co., Ltd.

Equities

2289

CNE1000023D6

Drug Retailers

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:27 2024-07-12 am EDT 		5-day change 1st Jan Change
8.6 HKD 0.00% Intraday chart for Charmacy Pharmaceutical Co., Ltd. 0.00% -33.64%
May. 21 Charmacy Pharmaceutical to Pay Final Dividend MT
May. 20 Charmacy Pharmaceutical Co., Ltd. Elects Ms. Zheng Xiyue as Employee Representative Supervisor of the Fourth Session of the Board of Supervisors CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 768.1 718.1 494.5 491 657.2 1,272
Enterprise Value (EV) 1 1,754 1,305 1,147 1,176 1,339 2,002
P/E ratio 16.9 x 17.9 x 12.2 x 21.2 x 7.27 x 24.8 x
Yield 4.22% 3.01% 4.37% - 7.4% 2.55%
Capitalization / Revenue 0.2 x 0.21 x 0.12 x 0.13 x 0.16 x 0.29 x
EV / Revenue 0.45 x 0.37 x 0.29 x 0.31 x 0.32 x 0.45 x
EV / EBITDA 15.2 x 12.6 x 11.1 x 11.6 x 11.2 x 15.6 x
EV / FCF -14.9 x 15.2 x -74.6 x -41.4 x -9.18 x 182 x
FCF Yield -6.73% 6.57% -1.34% -2.41% -10.9% 0.55%
Price to Book 1.61 x 1.48 x 0.98 x 0.97 x 1.11 x 2.13 x
Nbr of stocks (in thousands) 108,000 108,000 108,000 108,000 108,000 108,000
Reference price 2 7.112 6.649 4.579 4.547 6.085 11.78
Announcement Date 4/18/19 4/22/20 4/27/21 4/28/22 4/28/23 4/26/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 3,935 3,493 3,992 3,794 4,175 4,404
EBITDA 1 115.2 103.9 103.4 101.1 119.2 128.1
EBIT 1 98.62 84.74 83.52 73.9 93.49 108.3
Operating Margin 2.51% 2.43% 2.09% 1.95% 2.24% 2.46%
Earnings before Tax (EBT) 1 63.66 55.04 54.74 32.98 122.1 67.42
Net income 1 45.43 40.15 40.56 23.15 90.38 51.34
Net margin 1.15% 1.15% 1.02% 0.61% 2.16% 1.17%
EPS 2 0.4207 0.3718 0.3755 0.2144 0.8369 0.4754
Free Cash Flow 1 -118 85.69 -15.38 -28.39 -145.9 10.98
FCF margin -3% 2.45% -0.39% -0.75% -3.49% 0.25%
FCF Conversion (EBITDA) - 82.48% - - - 8.57%
FCF Conversion (Net income) - 213.41% - - - 21.39%
Dividend per Share 2 0.3000 0.2000 0.2000 - 0.4500 0.3000
Announcement Date 4/18/19 4/22/20 4/27/21 4/28/22 4/28/23 4/26/24
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 985 587 652 685 682 730
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 8.554 x 5.651 x 6.31 x 6.78 x 5.72 x 5.697 x
Free Cash Flow 1 -118 85.7 -15.4 -28.4 -146 11
ROE (net income / shareholders' equity) 9.52% 8.36% 8.23% 4.6% 16.5% 8.61%
ROA (Net income/ Total Assets) 2.55% 2.18% 1.97% 1.66% 2.08% 2.21%
Assets 1 1,779 1,841 2,060 1,394 4,354 2,320
Book Value Per Share 2 4.410 4.480 4.650 4.670 5.500 5.540
Cash Flow per Share 2 0.5200 4.690 5.470 5.830 4.560 5.870
Capex 1 97.7 73.9 52 25 8.59 40.8
Capex / Sales 2.48% 2.12% 1.3% 0.66% 0.21% 0.93%
Announcement Date 4/18/19 4/22/20 4/27/21 4/28/22 4/28/23 4/26/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Other Drug Retailers

1st Jan change Capi.
CHARMACY PHARMACEUTICAL CO., LTD. Stock Charmacy Pharmaceutical Co., Ltd.
-33.64% 119M
WALGREENS BOOTS ALLIANCE, INC. Stock Walgreens Boots Alliance, Inc.
-55.96% 9.93B
JD HEALTH INTERNATIONAL INC. Stock JD Health International Inc.
-41.82% 9.29B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED Stock Alibaba Health Information Technology Limited
-21.93% 6.82B
MATSUKIYOCOCOKARA & CO. Stock MatsukiyoCocokara & Co.
-2.08% 6.45B
CORPORATIVO FRAGUA, S.A.B. DE C.V. Stock Corporativo Fragua, S.A.B. de C.V.
+92.40% 5.26B
NAHDI MEDICAL COMPANY Stock Nahdi Medical Company
-2.63% 4.62B
CLICKS GROUP LIMITED Stock Clicks Group Limited
+5.79% 4.56B
YIFENG PHARMACY CHAIN CO., LTD. Stock Yifeng Pharmacy Chain Co., Ltd.
-31.67% 3.81B
REDCARE PHARMACY NV Stock Redcare Pharmacy NV
+4.94% 3.06B
Other Drug Retailers
  1. Stock Market
  2. Equities
  3. 2289 Stock
  4. Financials Charmacy Pharmaceutical Co., Ltd.